Literature DB >> 10821437

6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.

A Storch1, A Kaftan, K Burkhardt, J Schwarz.   

Abstract

6-Hydroxydopamine (6-OHDA) is widely used to generate animal models of Parkinson's disease. However, little is known about the intracellular events leading to cell death of dopaminergic neurones. Here we correlate indices of energy production and cell viability in human dopaminergic neuroblastoma SH-SY5Y cells after exposure to 6-OHDA. The toxin induces a time and dose-dependent decrease in cell survival with an IC50 value of 25 microM after 24 h. In contrast to the mitochondrial complex I inhibitor 1-methyl-4-phenylpyridinium (MPP+), 6-OHDA-induced reduction of cell viability is not associated with a decrease of intracellular ATP content, intracellular ATP/ADP ratio or NAD+ content. In addition, preventing or forcing glycolysis do not alter 6-OHDA toxicity. The antioxidant D-alpha-tocopherol can attenuate cell death induced by 6-OHDA. These results suggest that cell death induced by 6-OHDA is not due to an inhibition of mitochondrial energy supply, but probably involves production of free radicals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821437     DOI: 10.1007/s007020050023

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

2.  Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Authors:  Javier Iglesias-González; Sofía Sánchez-Iglesias; Estefanía Méndez-Álvarez; Sarah Rose; Atsuko Hikima; Peter Jenner; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2012-07-22       Impact factor: 3.996

Review 3.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

4.  Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.

Authors:  André Toulouse; Grace C Collins; Aideen M Sullivan
Journal:  Neurotox Res       Date:  2011-08-20       Impact factor: 3.911

Review 5.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

6.  Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.

Authors:  Jason Callio; Tim D Oury; Charleen T Chu
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

7.  The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.

Authors:  J Rodriguez-Pallares; J A Parga; B Joglar; M J Guerra; J L Labandeira-Garcia
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

8.  BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease.

Authors:  Pawel Kermer; Anja Köhn; Marlena Schnieder; Paul Lingor; Mathias Bähr; Jan Liman; Christoph Peter Dohm
Journal:  J Mol Neurosci       Date:  2014-08-09       Impact factor: 3.444

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.